Does the DESyne coronary stent system result in favorable clinical event rates in patients with ischemic heart disease?
The DESyne coronary stent system demonstrated favorable clinical outcomes in a Jordanian cohort of patients with ischemic heart disease.
Favorable clinical event rates including cardiac death, MI and stent thrombosis were observed for the DESyne stent in ischemic heart patients especially those with high prevalence of diabetes mellitus and acute coronary syndrome.
Jarrah et al. (2018) studied this question.